Cancer center tests new drug cocktail for Tough-to-Treat head and neck tumors
NCT ID NCT06046482
First seen Oct 31, 2025 · Last updated Apr 04, 2026 · Updated 21 times
Summary
This study tested whether adding an experimental drug called magrolimab to standard cancer drugs could help control advanced head and neck cancer. It aimed to see if this combination could shrink tumors and was safe for patients. The trial was for adults whose cancer had returned or spread and was terminated early after enrolling only four participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD NECK are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.